This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Beam Therapeutics Inc. (BEAM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BEAMNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains
by Urmimala Biswas
Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
earnings-estimates-revisions earnings-outlook earnings-preview earnings-report earnings-streak earnings-surprise healthcare medical medical-devices
Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval
by Zacks Equity Research
STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.
ISRGPositive Net Change STXSPositive Net Change MBOTPositive Net Change PRCTPositive Net Change
medical medical-devices
Buy, Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings
by Moumi Mondal
HOLX's fiscal Q4 2025 earnings may face limits as macro pressures and slow Diagnostics curb momentum.
BSXPositive Net Change MDTPositive Net Change HOLXNegative Net Change
earnings medical medical-devices
Here's How IDEXX Laboratories is Placed Ahead of Q3 Earnings
by Zacks Equity Research
IDXX heads into Q3 earnings with steady estimates and strong momentum across its diagnostics and pet healthcare segments.
IDXXNegative Net Change ANIPPositive Net Change EXASNegative Net Change EHCPositive Net Change
earnings medical medical-devices
Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing
by Zacks Equity Research
AVTR collaborates with BlueWhale Bio to speed CAR-T manufacturing using CDNP tech, aiming to scale production and expand patient access.
MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change AVTRPositive Net Change
medical medical-devices
5 Must-Buy Efficient Stocks to Increase Your Portfolio Returns
by Santanu Roy
From Red Robin to Analog Devices, these five high-efficiency stocks stand out for their strong ratios and surprise earnings potential.
ADINegative Net Change RRGBNegative Net Change ELMDNegative Net Change NCLHPositive Net Change TXGPositive Net Change
consumer-discretionary medical medical-devices restaurants semiconductor
Ericsson (ERIC) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ERICNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Karyopharm Therapeutics (KPTI)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
KPTINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Intuitive Surgical Pre-Q3 Analysis: Buy, Hold or Sell ISRG Stock Now?
by Indrajit Bandyopadhyay
Intuitive Surgical enters Q3 earnings season on strong momentum, backed by robust procedure growth and da Vinci 5 adoption. However, tariff risks and global CapEx constraints remain challenges.
BSXPositive Net Change ISRGPositive Net Change TMOPositive Net Change
medical medical-devices
WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure?
by Zacks Equity Research
West Pharma's Q3 numbers hinge on robust GLP-1 and biologics demand, but labor constraints, tariffs, and plant shutdowns could test its margin resilience.
MCKNegative Net Change EWPositive Net Change WSTNegative Net Change GMEDPositive Net Change
medical medical-devices
CVS Expands Its Nationwide Care Network With Rite Aid Acquisition
by Moumi Mondal
CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.
UNHPositive Net Change CAHPositive Net Change CVSPositive Net Change
medical medical-devices
Is AMLX Stock a Solid Choice Right Now?
by Zacks Equity Research
Amylyx has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
AMLXNegative Net Change
medical-devices
Reasons to Add HealthEquity Stock to Your Portfolio for Now
by Zacks Equity Research
HQY's strong Q2, expanding HSAs and AI-driven efficiencies highlight its growth momentum despite data security risks.
MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change HQYPositive Net Change
medical medical-devices
J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan
by Kinjel Shah
J&J's surprise plan to spin off its Orthopaedics unit as DePuy Synthes is aimed at sharpening MedTech focus and boosting growth margins.
JNJNegative Net Change MDTPositive Net Change SYKPositive Net Change KVUEPositive Net Change
medical medical-devices pharmaceuticals
Hims & Hers Elevates Technology-Driven Healthcare Accessibility
by Debanjana Dey
HIMS boosts AI-led care with new technology chief, hormone therapies and a global push via its ZAVA acquisition.
TDOCNegative Net Change HIMSNegative Net Change TEMNegative Net Change
medical medical-devices
Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings?
by Moumi Mondal
CVS Health prepares Q3 results, with pharmacy performance and Aetna's progress in focus for investors.
UNHPositive Net Change CVSPositive Net Change ELVPositive Net Change
earnings-preview medical medical-devices
Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition
by Zacks Equity Research
MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.
MASINegative Net Change MMSIPositive Net Change DRIOPositive Net Change NDRANegative Net Change
medical medical-devices
GEHC Stock Up Following New Launch to Streamline Perinatal Workflow
by Zacks Equity Research
GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery.
RMDPositive Net Change HCAPositive Net Change GEHCNegative Net Change SOLVPositive Net Change
medical medical-devices
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
by Zacks Equity Research
VEEV's strong Q2, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.
MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change VEEVPositive Net Change
medical medical-devices
Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs
by Zacks Equity Research
ABT's Q3 earnings meet expectations as revenues climb 6.9% year over year, driven by double-digit gains in Medical Devices.
ABTPositive Net Change PODDNegative Net Change PAHCPositive Net Change VCYTPositive Net Change
earnings medical medical-devices
Brookfield Infrastructure Partners (BIP)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BIPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Labcorp Gears Up to Report Q3 Earnings: What's in Store for the Stock?
by Zacks Equity Research
LH is poised for Q3 growth, with revenue and EPS estimates pointing higher as diagnostics and biopharma units deliver strong performances.
LHPositive Net Change IDXXNegative Net Change ANIPPositive Net Change EXASNegative Net Change
earnings medical medical-devices
Can Ion Emerge as ISRG's Vehicle to Tap Ambulatory Care Growth?
by Indrajit Bandyopadhyay
Intuitive Surgical's Ion platform gains traction in ambulatory centers, driving 52% growth as outpatient lung diagnostics accelerate.
BSXPositive Net Change BDXPositive Net Change ISRGPositive Net Change
medical medical-devices
Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now
by Zacks Equity Research
WST's growth prospects remain strong, fueled by GLP-1 demand and high-value products, though tariffs and execution risks weigh on margins.
CAHPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change
medical medical-devices